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Background: Hepatitis C virus is a small, enveloped single stranded, positive sense RNA 
virus. Different genotypes are distributed in different geographical areas of the world. 
Determination of HCV genotype is a powerful tool for the treatment of chronic and acute 
liver disease.  
Method: The present study was carried out to find the occurrence of different HCV 
genotypes in the city of Lahore, a populous city of Pakistan from January 2010 to December 
2010. Blood sample of patients positive for anti HCV by ELISA as well as HCV by PCR 
were collected and plasma was separated. HCV viral RNA load was analyzed in these 
samples using Real Time PCR. Qiagen HCV mini kit for RNA extraction and Qiagen HCV 
amplification kit for PCR amplification were used. Amplicons were subjected to HCV 
genotyping using Third Wave Technology.  
Results: Among 489 patients, 211 (43.1%) patients were males and 278 (56.9%) were 
females. Occurrence of HCV in the age group of 36-45 years was 32.5 %. Occurrence of 
HCV genotype 1 was 9.6% (47), genotype 3a was 80.77% (395), genotype 3h was 1.0% (5) , 
genotype 4 was 4.9% (24), co-infection of genotypes 1 & 2 was 0.2% (01), co-infection of 
genotypes 1 & 3 was 0.6% (03) and co-infection genotypes 1 & 4 was 0.4% (02).  
Conclusion: HCV genotype 3a is most prevalent HCV genotype in subjected population 
during said duration with most infected people from 26 to 35 years of age. Female population 
is having more of HCV infection as compared to males. 
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Introduction 
Infection with Hepatitis C Virus (HCV) is 
estimated at more than 200 million people 
worldwide, representing more than 3% of 
the world's population [1]. HCV consists of 
an envelope derived from host membranes 
into which are inserted the virally encoded 
glycoproteins E1 and E2, surrounding a 
nucleocapsid and a positive sense single 
stranded RNA genome which has been 
characterized and sequenced [2]. 
Phylogenetic analysis of HCV sequence has 
revealed 6 major genotypes and more than 
50 subtypes [3,4]. HCV genotypes differ 
from each other in their nucleotide sequence 
by 31-34% and in their amino acid sequence 
by 30% [5]. The genotype determination is a 
relevant clinical practice. It helps to predict 
the probability of sustained virological 
response i.e. 40%-45% for genotype 1 as 
compared with 70%-80% for genotypes 2 
and 3. It is also used routinely to determine 
duration of treatment i.e. 48 weeks for 
genotypes 1 & 4, and 24 weeks for 
genotypes 2 and 3 [6]. 
Genotypes 1, 2 and 3 are distributed 
almost worldwide [7,8]. Half of the hepatitis 
C patients from South of Brazil were 
infected by genotypes 2 and 3 [9]. Types 4, 
5 and 6 have been found in distinct 
geographical areas [3,8,10]. Genotype 5 is 
mainly dominant in South Africa and also 
present in less percentage in other countries 
[11]. Genotype 6 is common in South East 
Asia, Asian countries and Asian Australians 
[12]. In Romania, HCV subtype 1a was 5.4 
%, subtype 1b was 92.6%, subtype 3a was 
0.8% and subtype 4a was 1.2% [13]. In the 
Swat district of Pakistan, HCV genotype 3a 
had been reported to be predominant 
followed by mixed genotype infection and 
then 3b [14]. Genotype 7, 8 and 9 had been 
reported from Vietnam [15]. Genotype 10 
and 11 were identified in patients from 
Indonesia but there had been a conflict for 
the classification of HCV isolate and 
scientists proposed that genotypes 7 through 
11 must be  considered as variants of the 
same group and must be classified as a 
single genotype, type 6 [15,16]. From 
Pakistan, few studies are available on the 
distribution of various HCV genotypes and 
its route of transmission based on small 
sample sizes [17-19]. 
Methods 
All the work was done in PCR section of 
Pathology Department, Jinnah Hospital, 
Lahore from January 2010 to December 
2010. Three milliliter blood sample was 
collected from each of 489 HCV positive 
patients along with their age, gender and 
place of living. Plasma was separated from 
each sample using the recommended 
standard procedure given by Qiagen 
extraction kit. Extraction of HCV RNA from 
each sample was done using QIAamp Viral 
mini kit by Qiagen cat no. 52906. 
Amplification was achieved by using Atrus 
HCV RT-PCR kit by Qiagen from Germany. 
HCV genotyping of amplified samples was 
detected using Invader HCV Reagents on 
Palm Cycler for amplification and Cytoflour 
for detection of genotype. The 
Invader® chemistry is composed of two 
simultaneous isothermal reactions. A 
primary reaction specifically and accurately 
detects single-base changes, insertions, 
deletions and changes in gene and 
Full Length Research Article 
   
91 | A d v a n c e m e n t s  i n  L i f e  S c i e n c e s  V o l .  1 ,  I s s u e  2  
 
chromosome number for genetic, 
pharmacogenetic and infectious diseases. A 
second reaction is used for signal 
amplification and generic Present study was 
carried out to find the occurrence of 
different HCV Genotypes in the city of 
Lahore, Punjab of Pakistan. In the present 
study a total number of 489 HCV positive 
cases (which were also anti HCV positive by 
ELISA) were selected. HCV load was 
analyzed in these samples using Real Time 
PCR. Genotypes of all samples were 
determined using Third Wave Technology. 
Results 
Among 489 patients 211 (43.1%) patients 
were male and 278 (56.9%) were female. 
Out of 211 (43.1%) anti HCV positive 
males, 24 (4.9%) had HCV genotype 1, 168 
(35.4%) had HCV genotype 3a, 03 (0.6%) 
had HCV genotype 3h, 10 (2.0%) had HCV 
genotype 4, 01 (0.2%) had co-infection of 
genotypes 1 & 3 and untypable were 5 
(1.02%). Among 278 (56.9%) anti HCV 
positive females, 23 (4.7%) had HCV 
genotype 1, 227 (46.4%) had HCV genotype 
3a, 02 (0.4%) had HCV genotype 3h, 
14(2.9%) had HCV genotype 4, 01 (0.2%) 
had co-infection of genotypes 1 & 2, 02 
(0.4%) had co-infection of genotypes 1 & 3 
and 02 (0.4%) had co infection of genotypes 
1 & 4 and untypable were only 7 (1.43%) 
[Table I]. 
Out of 489 patients, 15.5% (76) were 
from 15-25 years age group. Out of which 
2.0% (10) had HCV genotype 1, 12.3% (60) 
had HCV genotype 3a, 0.8% (04) had HCV 
genotype 4, 0.2% (01) was co infected with 
HCV genotypes 1&3 and 0.2% (01) was co 
infected with HCV genotypes 1 & 4.  Out of 
489 patients, 33.9% (166) were from 26-35 
years age group. 
Out of 489 patients, 15.5% (76) were 
from 15-25 years age group. Out of which 
2.0% (10) had HCV genotype 1, 12.3% (60) 
had HCV genotype 3a, 0.8% (04) had HCV 
genotype 4, 0.2% (01) was co infected with 
HCV genotypes 1&3 and 0.2% (01) was co 
infected with HCV genotypes 1 & 4.  Out of 
489 patients, 33.9% (166) were from 26-35 
years age group. Out of which 2.9% (14) 
had HCV genotype 1, 27.4% (134) had 
HCV genotype 3a, 0.6% (03) patients had 
HCV genotype 3h, 2.0% (10) had HCV 
genotype 4 and 0.2% (01) was co infected 
with genotypes 1 & 3. Out of 489 patients, 
32.5% (159) were from 36-45 years age 
group. Out of which 2.5% (12) had HCV 
genotype 1, 27.4% (134) had HCV genotype 
3a, 0.2% (01) had HCV genotype 3h, 1.2%  
HCV Genotype Male Female Total 
Type 1 24 (4.9%) 23 (4.7%) 47(9.6%) 
 
Type 3a 168 (34.4%) 227 (46.4%) 395 (80.8%) 















Type 1& 3  
Co-infection 


















Table I: Distribution of HCV genotypes with genders 
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(06) had HCV genotype 4, 0.2% (01)was co-
infected with HCV genotypes 1 & 2 and 
0.2% (01) was co-infected with HCV 
genotypes 1 & 4.  Out of 489 patients, 
13.5% (66) were from 46-55 years age 
group, out of which  1.7% (08) had HCV 
genotype 1, 10.6% (52) had HCV genotype 
3a, 0.2% (01) had HCV genotype 3h, 0.8% 
(04) had HCV genotype 4 and 0.2% (01) 
was co-infected with HCV genotypes 1 & 3. 
Out of 489 patients, 3.7% (18) were from 
56-65 years age group. Out of which only 
0.4% (02) had HCV genotype 1 and 3.3% 
(16) had HCV genotype 3a. 489 0.8% (04) 
patients were from > 65 years age group. 
Out of which 0.2% (01) had HCV genotype 
1 and 0.6% (03) had HCV genotype 3a 
[Table II]. 
Among 489 anti HCV positive cases on 
ELISA, occurrence of HCV genotype 1 was 
9.6% (47) , genotype 3a was 80.77% (395), 
genotype 3h was 1% (05) , genotype 4 was 
4.9% (240) , co infection of genotypes 1 & 2 
was 0.2% (01) , co infection of genotypes 1 
& 3 was 0.6% (03) and co infection 
genotypes 1 & 4 was 0.4% (02) and 
untypable were 2.45% (12) [Table III]. 
Discussion 
Interest of HCV genotyping by group 
screening is increased many fold as it is 
useful for the solution of epidemiological 
questions and development of vaccines 
against HCV. It has also been shown to be 
valuable to facilitate therapeutic decisions 
and strategies [20,21]. Severity, progression 
and response to the treatment of disease 
HCV Genotype Frequency Percent 
Type 1 47 9.6 
Type 3a 395 80.77 
Type 3h 05 1.0 
Type 4 24 4.9 
Type 1 & 2 Co infection 01 0.2 
Type 1 & 3 Co infection 03 0.6 
Type 1 & 4 Co infection 02 0.4 
Untypable 12 2.45 
Total 489 99.9 
Table III: Occurrence of HCV genotypes 
 
Age Groups Type 1 Type 3a Type 3h Type 4 Type 1 & 2  
co-infection 
Type 1 & 3  
co-infection 
Type 1 & 4  
co-infection 
Untypable Total 
15-25 Years 10 (2.0%) 60 (12.3%) - 04 (0.8%) - 01 (0.2%) 01 (0.2%) - 76 (15.5%) 
26-35 Years 14 (2.9%) 130 (26.5%) 03 (0.6%) 10 (2.0%) - 01 (0.2%) - 08 (1.7%) 166 (33.9%) 
36-45 Years 12 (2.5%) 134 (27.4%) 01 (0.2%) 06 (1.2%) 01 (0.2%) - 01 (0.2%) 04 (0.8%) 159 (32.5%) 
46-55 Years 08 (1.7%) 52 (10.6%) 01 (0.2%) 04 (0.8%) - 01 (0.2%) - - 66 (13.5%) 
56-65 Years 02 (0.4%) 16 (3.3%) - - - - - - 18 (3.7%) 
> 65 Years 01 (0.2%) 03 (0.6%) - - - - - - 04 (0.8%) 
Total 47 (9.6%) 395 (80.77%) 05 (1.0%) 24 (4.9%) 01 (0.2%) 03 (0.6%) 02 (0.4%) 12 (2.4%) 489 (99.9 
%) 
Table II: Distribution of HCV genotypes with age groups 
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caused by HCV vary according to the 
genotype of HCV [22,23]. 
Knowledge of occurrence of different 
HCV genotypes in different areas of 
Pakistan will help in therapeutic 
implications. In the present study, 
occurrence of various genotypes of HCV, in 
Lahore city, were observed. All plasma 
samples were anti HCV positive on ELISA 
and thus were further tested for HCV 
genotyping. The data shows that HCV 
infection is more common in females 
residing in Lahore as compared to males 
[20]. Results were analyzed by keeping the 
age and gender categorical variable and 
patients were divided in six different age 
groups. It is found that patients belonging to 
age group 26-35 years are more infected 
with HCV followed by the age group of 36-
45 years. A similar reported same kind of 
results that people ≤ 40 years of age were 
more affected with HCV in comparison to 
those > 40 years of age in Lahore [24]. A 
study reported that HCV prevalence 
observed was highest among an age group 
of 13-50 years [25]. In present study 
prevalence of HCV genotypes is also 
recorded with reference to gender and it is 
found that highest prevalence of type 3 
exists among both genders. Genotype 3a 
predominates among the patients residing in 
Lahore, genotype 1 and genotype 4 follows 
it. This data favors the results of Ahmad 
who reported that the most commonly 
detected genotype in their study was 
genotype 3 (59.1%), with predominant 
subtype 3a (55.9%) and 3b (3.2%) [24]. 
Genotype 1a was (23.6%) while genotype 4 
(13.7%) comprised of the subtypes a 
(12.5%) and b (1.2%). It is also reported the 
occurrence of HCV genotype 3a in 40.96%, 
3b in 15.66%, 1a in 9.63%, and 1b in 2.40% 
of hepatocellular carcinoma tissue (HCT) 
samples [26]. They also found 24 (28.91%) 
mixed types. Another study by Butt et al., in 
2010 showed prevalence of 3a (62%), 3b 
(9%), 1a (3%), 2a (2.144%), mixed 
(4.718%) and un type able (17.16%) [27]. 
Another study reported that genotype 1 was 
the most frequently genotype found in all 
regions of Brazil. In present study 
prevalence of mixed infection is quite 
negligible [28]. 
This is dire need to carry out a detailed 
study on patterns of HCV genotype amongst 
the population of Lahore for the proper and 
better control on spread of disease. 
Conclusions 
 Anti HCV positivity was relatively more 
predominant in females than male 
population. 
 HCV RNA was common in the age 
group of 26-35 followed by the age 
group of 36-45 years. 
 Genotype 3a was the common genotype 
found in the population of the city of 
Lahore, Pakistan and it was also the 
common genotype in both males and 
females. 
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